GLUTATHIONE-S-TRANSFERASE ACTIVITY AND ISOENZYME DISTRIBUTION IN OVARIAN TUMOR-BIOPSIES TAKEN BEFORE OR AFTER CYTOTOXIC CHEMOTHERAPY

被引:47
作者
MURPHY, D
MCGOWN, AT
HALL, A
CATTAN, A
CROWTHER, D
FOX, BW
机构
[1] CHRISTIE HOSP NHS TRUST,PATERSON INST CANC RES,CANC RES CAMPAIGN,DEPT EXPTL CHEMOTHERAPY,MANCHESTER M20 9BX,ENGLAND
[2] UNIV MANCHESTER,CHRISTIE HOSP NHS TRUST,CANC RES CAMPAIGN,DEPT MED ONCOL,MANCHESTER M20 9BX,ENGLAND
[3] UNIV NEWCASTLE UPON TYNE,LRF LAB,NEWCASTLE TYNE NE2 4HH,ENGLAND
关键词
D O I
10.1038/bjc.1992.389
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A study involving the measurement of glutathione S-transferase activities and isoenzyme distributions in human ovarian tumours has been carried out. These tumours have been obtained either at initial debulking surgery, prior to cytotoxic chemotherapy, or at second look laparotomy following chemotherapy. The response rates of these two groups to chemotherapy differ markedly, with patients who have relapsed following initial chemotherapy showing a reduction in response rates to subsequent chemotherapy. Analysis of these data show no statistically significant differences between the glutathione S-transferase activity or isoenzyme distribution in these two groups of patients. Significant differences were observed in the glutathione-S-transferase activities (GST) between tumours and normal ovaries. GST activities in pre-chemotherapy tumours (n = 33, P = 0.01) and post-chemotherapy tumours (n = 20, P = 0.001) where significantly higher than the GST activity in normal ovaries (n = 15). One feature was the expression of the basic isoenzyme which is expressed more in normal ovaries than in tumours. No differences in these parameters were observed in normal peritoneal tissue taken from patients before or after chemotherapy. These data do not support the hypothesis that changes in glutathione S-transferase enzyme activity or isoenzyme expression are major determinants of response to chemotherapy in ovarian tumours.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 12 条
[1]   DETERMINANTS OF DRUG RESPONSE IN A CISPLATIN-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
FUJIWARA, Y ;
SUGIMOTO, Y ;
KASAHARA, K ;
BUNGO, M ;
YAMAKIDO, M ;
TEW, KD ;
SAIJO, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (05) :527-535
[2]  
GURNEY H, 1990, ANN ONCOL, V1, P427
[3]  
HABIG WH, 1974, J BIOL CHEM, V249, P7130
[4]   PURIFICATION AND CHARACTERIZATION OF A PI CLASS GLUTATHIONE-S-TRANSFERASE FROM HUMAN LEUKEMIC-CELLS [J].
HALL, A ;
FOSTER, S ;
PROCTOR, SJ ;
CATTAN, AR .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (04) :494-500
[5]   GLUTATHIONE AND GLUTATHIONE-DEPENDENT ENZYMES IN OVARIAN ADENOCARCINOMA CELL-LINES DERIVED FROM A PATIENT BEFORE AND AFTER THE ONSET OF DRUG-RESISTANCE - INTRINSIC DIFFERENCES AND CELL-CYCLE EFFECTS [J].
LEWIS, AD ;
HAYES, JD ;
WOLF, CR .
CARCINOGENESIS, 1988, 9 (07) :1283-1287
[6]  
MCGOWN AT, 1986, CANCER CHEMOTH PHARM, V17, P223
[7]   THE RELATIONSHIPS BETWEEN GLUTATHIONE, GLUTATHIONE-S-TRANSFERASE AND CYTOTOXICITY OF PLATINUM DRUGS AND MELPHALAN IN 8 HUMAN OVARIAN-CARCINOMA CELL-LINES [J].
MISTRY, P ;
KELLAND, LR ;
ABEL, G ;
SIDHAR, S ;
HARRAP, KR .
BRITISH JOURNAL OF CANCER, 1991, 64 (02) :215-220
[8]  
NAKAGAWA K, 1990, J BIOL CHEM, V265, P4296
[9]  
Nash J D, 1988, Cancer Chemother Biol Response Modif, V10, P291
[10]  
OZOLS RF, 1984, SEMIN ONCOL, V11, P251